J&J Hit With Suit Over Stelara Exclusivity - Law360

J&J Hit With Suit Over Stelara Exclusivity – Law360

Source Node: 3001738
By Adam Lidgett (December 8, 2023, 3:42 PM EST) — A group of Blue Cross and Blue Shield licensees have filed a lawsuit in Virginia federal court claiming Johnson & Johnson has been trying to stifle competition in the market for the immunosuppressive drug Stelara, saying it defrauded federal patent officials….

Time Stamp:

More from Law 360